Physician profile
Daniel Mcgee
NPI 1538130554
$3,498.12
in general payments reported to CMS, 2019-2025
12 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,727 · 2021: $178 · 2022: $1,340 · 2023: $53.64 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $253.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,702.00 | 2019 | |
| Seapearl East, INC | $1,210.15 | 2022 | |
| Stryker Corporation | $203.00 | 2023-2025 | Augment Injectable, Biofoam |
| Treace Medical Concepts, INC. | $168.90 | 2021-2022 | |
| Abbott Laboratories | $63.70 | 2022 | |
| Organogenesis INC. | $29.12 | 2021-2023 | Puraply |
| Integra Lifesciences Corporation | $28.89 | 2022 | |
| Smith+Nephew, INC. | $27.38 | 2025 | Collagenase Santyl, Renasys Go V2 Home |
| Fidia Pharma USA INC. | $24.91 | 2019 | |
| Depuy Synthes Sales INC. | $20.17 | 2022 | |
| Zimmer Biomet Holdings, INC. | $11.64 | 2021 | |
| Orthofix Medical, INC. | $8.26 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Mcgee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.